Muirfield Wealth Advisors LLC Has $313,000 Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Muirfield Wealth Advisors LLC lessened its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 19.0% in the first quarter, according to the company in its most recent filing with the SEC. The fund owned 597 shares of the healthcare conglomerate’s stock after selling 140 shares during the quarter. Muirfield Wealth Advisors LLC’s holdings in UnitedHealth Group were worth $313,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also bought and sold shares of the company. Capital & Planning LLC increased its holdings in shares of UnitedHealth Group by 19.2% during the fourth quarter. Capital & Planning LLC now owns 491 shares of the healthcare conglomerate’s stock worth $248,000 after purchasing an additional 79 shares during the period. Brighton Jones LLC increased its stake in UnitedHealth Group by 176.2% during the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock worth $22,384,000 after acquiring an additional 28,231 shares during the period. Union Bancaire Privee UBP SA bought a new stake in shares of UnitedHealth Group during the 4th quarter valued at $27,233,000. Revolve Wealth Partners LLC raised its stake in UnitedHealth Group by 137.1% in the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock valued at $2,033,000 after purchasing an additional 2,324 shares in the last quarter. Finally, Vest Financial LLC grew its stake in UnitedHealth Group by 20.6% during the fourth quarter. Vest Financial LLC now owns 7,043 shares of the healthcare conglomerate’s stock worth $3,563,000 after buying an additional 1,204 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insiders Place Their Bets

In other news, Director Timothy Patrick Flynn acquired 1,533 shares of the firm’s stock in a transaction dated Wednesday, May 14th. The stock was purchased at an average price of $320.80 per share, for a total transaction of $491,786.40. Following the completion of the acquisition, the director now directly owns 6,033 shares in the company, valued at $1,935,386.40. The trade was a 34.07% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CFO John F. Rex bought 17,175 shares of the business’s stock in a transaction that occurred on Friday, May 16th. The stock was purchased at an average price of $291.12 per share, for a total transaction of $4,999,986.00. Following the completion of the acquisition, the chief financial officer now owns 203,796 shares in the company, valued at $59,329,091.52. This represents a 9.20% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last three months, insiders have acquired 109,408 shares of company stock worth $31,607,768. Corporate insiders own 0.33% of the company’s stock.

Analysts Set New Price Targets

A number of analysts have recently weighed in on UNH shares. Barclays cut their price target on shares of UnitedHealth Group to $350.00 and set an “overweight” rating for the company in a report on Monday, June 2nd. Truist Financial reaffirmed a “buy” rating and issued a $360.00 target price (down previously from $580.00) on shares of UnitedHealth Group in a report on Monday, May 19th. Raymond James downgraded UnitedHealth Group from a “strong-buy” rating to a “market perform” rating in a research report on Wednesday, May 14th. Oppenheimer decreased their target price on UnitedHealth Group from $600.00 to $400.00 and set an “outperform” rating on the stock in a research report on Wednesday, May 14th. Finally, Bank of America lowered shares of UnitedHealth Group from a “buy” rating to a “neutral” rating and decreased their price target for the company from $560.00 to $350.00 in a report on Wednesday, May 14th. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating and seventeen have assigned a buy rating to the company. According to data from MarketBeat, UnitedHealth Group has an average rating of “Moderate Buy” and an average target price of $428.43.

UnitedHealth Group Price Performance

UnitedHealth Group stock opened at $303.24 on Monday. The firm has a market cap of $275.08 billion, a P/E ratio of 19.56, a P/E/G ratio of 1.37 and a beta of 0.44. The stock’s 50 day moving average is $409.03 and its 200 day moving average is $482.60. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a one year low of $248.88 and a one year high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). The firm had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same period in the prior year, the company posted $6.91 earnings per share. As a group, research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 24th. Investors of record on Monday, June 16th will be paid a dividend of $2.21 per share. The ex-dividend date of this dividend is Monday, June 16th. This represents a $8.84 annualized dividend and a yield of 2.92%. This is a boost from UnitedHealth Group’s previous quarterly dividend of $2.10. UnitedHealth Group’s dividend payout ratio (DPR) is currently 37.02%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.